Staying Diversified, Bayer Sees Opportunities In Digital Innovation
Pharma Has Missed Digital Health Potential
Executive Summary
Despite its Monsanto woes, Bayer is sticking with its diversified portfolio, and is branching out into patient-facing digital health services.